CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells.

Hanbing Jiang, Siying Zhu, Bin Wu, Yinyin Su, Qiming Wang, Yonghua Lei, Qiuju Shao, Yun Gao, Ke Gao, Guojun Wu

Chemico-biological interactions 2023 Sep 01

filter terms:

Bladder cancer (BCa) is a urinary tumor with limited treatment options and high mortality. Liensinine (LIEN), a natural bisbenzylisoquinoline alkaloid, has shown excellent anti-tumor effects in numerous preclinical studies. However, the anti-BCa effect of LIEN remains unclear. To the best of our knowledge, this is the first study to investigate the molecular mechanism of LIEN in the management of BCa. First, we identified the treatment-related targets of BCa; those that repeatedly occur in more than two databases, including GeneCards, Online Mendelian Inheritance in Man, DisGeNET, Therapeutic Target Database, and Drugbank. The SwissTarget database was used to screen LIEN-related targets, and those with a probability >0 were possible LIEN targets. The prospective targets of LIEN in the treatment of BCa were then determined using a Venn diagram. Second, we discovered that the PI3K/AKT pathway and senescence mediated the anti-BCa action of LIEN by using GO and KEGG enrichment analysis to explore the function of LIEN therapeutic targets. A protein-protein interaction network was created using the String website, and six algorithms of the CytoHubba plug-in were then used in Cytoscape to assess the core targets of LIEN for the therapy of BCa. The outcomes of molecular docking and dynamics simulation demonstrated that CDK2 and CDK4 proteins were the direct targets of LIEN in the management of BCa, among which CDK2 was more stable in binding to LIEN than CDK4. Finally, in vitro experiments showed that LIEN inhibited the activity and proliferation of T24 cells. The expression of p-/AKT, CDK2, and CDK4 proteins progressively decreased, while the expression and fluorescence intensity of the senescence-related protein, γH2AX, gradually increased with increasing LIEN concentration in T24 cells. Therefore, our data suggest that LIEN may promote senescence and inhibit proliferation by inhibiting the CDK2/4 and PI3K/AKT pathways in BCa. Copyright © 2023 Elsevier B.V. All rights reserved.

Citation

Hanbing Jiang, Siying Zhu, Bin Wu, Yinyin Su, Qiming Wang, Yonghua Lei, Qiuju Shao, Yun Gao, Ke Gao, Guojun Wu. CDK2 and CDK4 targeted liensinine inhibits the growth of bladder cancer T24 cells. Chemico-biological interactions. 2023 Sep 01;382:110624